| Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. A Dondorp, F Nosten, K Stepniewska, N Day, N White Lancet (London, England) 366 (9487), 717-725, 2005 | 1054* | 2005 |
| Vivax malaria: neglected and not benign RN Price, E Tjitra, CA Guerra, S Yeung, NJ White, NM Anstey The American journal of tropical medicine and hygiene 77 (6_Suppl), 79-87, 2007 | 917 | 2007 |
| Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number RN Price, AC Uhlemann, A Brockman, R McGready, E Ashley, L Phaipun, ... The Lancet 364 (9432), 438-447, 2004 | 864 | 2004 |
| Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia E Tjitra, NM Anstey, P Sugiarto, N Warikar, E Kenangalem, M Karyana, ... PLoS Med 5 (6), e128, 2008 | 663 | 2008 |
| Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study F Nosten, M Van Vugt, R Price, C Luxemburger, KL Thway, A Brockman, ... The Lancet 356 (9226), 297-302, 2000 | 585 | 2000 |
| Effects of artemisinin derivatives on malaria transmissibility RN Price, F Nosten, C Luxemburger, FO Ter Kuile, L Paiphun, ... The Lancet 347 (9016), 1654-1658, 1996 | 579 | 1996 |
| A long neglected world malaria map: Plasmodium vivax endemicity in 2010 PW Gething, IRF Elyazar, CL Moyes, DL Smith, KE Battle, CA Guerra, ... PLoS Negl Trop Dis 6 (9), e1814, 2012 | 561 | 2012 |
| The pathophysiology of vivax malaria NM Anstey, B Russell, TW Yeo, RN Price Trends in parasitology 25 (5), 220-227, 2009 | 468 | 2009 |
| Factors contributing to anemia after uncomplicated falciparum malaria. RN Price, JA Simpson, F Nosten, C Luxemburger, L Hkirjaroen, F ter Kuile, ... The American journal of tropical medicine and hygiene 65 (5), 614-622, 2001 | 407 | 2001 |
| New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance RN Price, NM Douglas, NM Anstey Current opinion in infectious diseases 22 (5), 430-435, 2009 | 386 | 2009 |
| The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparumfrom the western border of Thailand RN Price, C Cassar, A Brockman, M Duraisingh, M Van Vugt, NJ White, ... Antimicrobial agents and chemotherapy 43 (12), 2943-2949, 1999 | 330 | 1999 |
| Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. R Price, M Van Vugt, L Phaipun, C Luxemburger, J Simpson, R McGready, ... The American journal of tropical medicine and hygiene 60 (4), 547-555, 1999 | 325 | 1999 |
| Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria RN Price, AC Uhlemann, M van Vugt, A Brockman, R Hutagalung, S Nair, ... Clinical Infectious Diseases 42 (11), 1570-1577, 2006 | 298 | 2006 |
| Impaired nitric oxide bioavailability and L-arginine–reversible endothelial dysfunction in adults with falciparum malaria TW Yeo, DA Lampah, R Gitawati, E Tjitra, E Kenangalem, YR McNeil, ... Journal of Experimental Medicine 204 (11), 2693-2704, 2007 | 289 | 2007 |
| Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis RN Price, L Von Seidlein, N Valecha, F Nosten, JK Baird, NJ White The Lancet infectious diseases 14 (10), 982-991, 2014 | 275 | 2014 |
| Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment VI Carrara, J Zwang, EA Ashley, RN Price, K Stepniewska, M Barends, ... PloS one 4 (2), e4551, 2009 | 272 | 2009 |
| Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison A Ratcliff, H Siswantoro, E Kenangalem, R Maristela, RM Wuwung, ... The Lancet 369 (9563), 757-765, 2007 | 267 | 2007 |
| The relationship between age and the manifestations of and mortality associated with severe malaria AM Dondorp, SJ Lee, MA Faiz, S Mishra, R Price, E Tjitra, M Than, Y Htut, ... Clinical Infectious Diseases 47 (2), 151-157, 2008 | 264 | 2008 |
| A novel multiple-stage antimalarial agent that inhibits protein synthesis B Baragaņa, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ... Nature 522 (7556), 315-320, 2015 | 263 | 2015 |
| Risk factors for gametocyte carriage in uncomplicated falciparum malaria. R Price, F Nosten, JA Simpson, C Luxemburger, L Phaipun, F Ter Kuile, ... The American journal of tropical medicine and hygiene 60 (6), 1019-1023, 1999 | 249 | 1999 |
Nicholas AnsteyMenzies School of Health ResearchVerified email at menzies.edu.au
